Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALS LIMITED Investor Presentation 2013

Apr 4, 2013

64365_rns_2013-04-04_07a7a148-41e8-481c-aa87-c49a187d2f07.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

==> picture [720 x 293] intentionally omitted <==

Investor Briefing

Singapore & United Kingdom April 2013 Greg Kilmister - CEO

==> picture [100 x 97] intentionally omitted <==

RIGHT SOLUTIONS | RIGHT PARTNER

IMPORTANT NOTICE AND DISCLAIMER

==> picture [45 x 44] intentionally omitted <==

  • This presentation has been prepared by ALS Limited, ( ALS or the Company ). It contains general information about the Company’s activities as at the date of the presentation. It is information given in summary form and does not purport to be complete. The distribution of this presentation in jurisdictions outside Australia may be restricted by law, and you should observe any such restrictions.

  • This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy, securities in any jurisdiction. Neither this document nor anything in it shall form the basis of any contract or commitment. This presentation is not intended to be relied upon as advice to investors or potential investors and does not take into account the investment objectives, financial situation or needs of any investor. All investors should consider such factors in consultation with a professional advisor of their choosing when deciding if an investment is appropriate.

  • The Company has prepared this presentation based on information available to it, including information derived from public sources that have not been independently verified. No representation or warranty, express or implied, is provided in relation to the fairness, accuracy, correctness, completeness or reliability of the information, opinions or conclusions expressed herein.

  • This presentation includes forward-looking statements within the meaning of securities laws. Any forwardlooking statements involve known and unknown risks and uncertainties, many of which are outside the control of the Company and its representatives. Forward-looking statements may also be based on estimates and assumptions with respect to future business decisions, which are subject to change. Any statements, assumptions, opinions or conclusions as to future matters may prove to be incorrect, and actual results, performance or achievement may vary materially from any projections and forward-looking statements.

  • Due care and attention should be undertaken when considering and analysing the financial performance of the Company.

  • All references to dollars are to Australian currency unless otherwise stated.

2

ALS Company History

Soap & Chemical Company Established

1863

Listed on ASX

1952

==> picture [45 x 44] intentionally omitted <==

Modern Era

2013

ALS Limited – Today

  • Market Capitalization AUD$3.5 billion

  • Fourth largest public listed TIC company in the world

ASX 100 participant (Sept 2011)

Annual Revenues +AUD$1.4 billion

12,000 Staff

Operations in 56 countries on 6 continents

Conservative Funding – 28% gearing

Commitment to technical excellence

3

Last Financial Release – September 2012 Half Year

==> picture [45 x 44] intentionally omitted <==

H1 H2 H1
half year FY12 FY12 FY13
(AUD$m) (AUD$m) (AUD$m)
Revenue 667.5 738.1 813.6
EBITDA1 172.0 201.8 227.5
EBITDA1,2from continuing operations 168.3 196.6 223.4
Gain on sale of discontinued
operations
- - 5.8
Impairment - - (6.1)
EBIT1 150.1 177.5 200.5
NPAT 102.3 120.1 135.5
EPS (basic – cents per share) 30.3 35.6 39.8
Dividend (cents per share) 19 26 21

1 Excludes gain on sale of discontinued operations and impairment loss

2 EBITDA from continuing operations post the sale of the Chemical Division (Deltrex and Panamex)

4

Revenue Growth

==> picture [45 x 44] intentionally omitted <==

ALS (laboratories) Revenue Growth

  • Organic Growth 15%

  • Acquired Growth 12%

  • Currency Impact 0%

Reported Growth 27%

==> picture [42 x 170] intentionally omitted <==

----- Start of picture text -----

800
700
600
500
400
300
200
100
0
Revenue (AUD$mn)
----- End of picture text -----

==> picture [208 x 145] intentionally omitted <==

==> picture [109 x 44] intentionally omitted <==

Revenue Growth H1 2013 Vs H1 2012

==> picture [654 x 143] intentionally omitted <==

----- Start of picture text -----

Industrial
Energy
Life Sciences
Minerals
-5% 0% 5% 10% 15% 20% 25% 30% 35%
Organic Acquired FX Movement
----- End of picture text -----

5

ALS Divisional Structure

==> picture [176 x 96] intentionally omitted <==

  • Four Global Divisions

  • • Ten Business Streams

==> picture [324 x 79] intentionally omitted <==

==> picture [10 x 308] intentionally omitted <==

==> picture [193 x 77] intentionally omitted <==

==> picture [193 x 71] intentionally omitted <==

==> picture [194 x 72] intentionally omitted <==

==> picture [45 x 44] intentionally omitted <==

==> picture [177 x 407] intentionally omitted <==

----- Start of picture text -----

13%
7%
49%
31%
Revenue 2012 – AUD$1.2 billion
Strategy
20%
33%
14%
33%
----- End of picture text -----

Revenue 2012 – AUD$1.2 billion

Revenue 2017 – AUD$2.0 billion

6

Global Diversification & Technical Leadership

==> picture [45 x 44] intentionally omitted <==

>12,000 staff

==> picture [101 x 92] intentionally omitted <==

==> picture [101 x 91] intentionally omitted <==

>$1.3 billion 56 revenue countries +20 million >300 samples/year laboratories 9 service lines

==> picture [96 x 91] intentionally omitted <==

==> picture [99 x 90] intentionally omitted <==

==> picture [583 x 189] intentionally omitted <==

7

ALS - laboratory revenue & staff distribution

==> picture [45 x 44] intentionally omitted <==

==> picture [679 x 408] intentionally omitted <==

----- Start of picture text -----

15%
20%
29%
4%
24%
10%
5%
7%
10%
Revenue
>$1.3 40%
billion 10%
26%
Staff
11,000
----- End of picture text -----

8

Diversification & Consistent Growth

==> picture [45 x 44] intentionally omitted <==

==> picture [636 x 402] intentionally omitted <==

----- Start of picture text -----

1400 1,000
100
1200
10
1
1000
Financial Year – ending March
800
SECTOR
600 MINERALS LIFE SCIENCES ENERGY INDUSTRIAL
7% [13% ]
400 47%
33%
200
0
Financial Year – ending March
Revenue ($ million)
----- End of picture text -----

9

Revenue Growth + Margin Strength

==> picture [45 x 44] intentionally omitted <==

==> picture [15 x 224] intentionally omitted <==

----- Start of picture text -----

ALS Revenue AUD$ million
----- End of picture text -----

==> picture [613 x 352] intentionally omitted <==

----- Start of picture text -----

1,500 35%
Core Labs
1,200 30%
ALS
900 25%
SGS
600 20%
Intertek
Bureau Veritas
Eurofins
300 15%
0 10%
2007 2008 2009 2010 2011 2012 2013
ALS Financial Year Ending March
ALS EBITDA Margin ALS Revenue
EBITDA Margin
----- End of picture text -----

EBITDA Margin for Core Labs, SGS, Intertek, Bureau Veritas & Eurofins is for Calendar Year 2012 actual.

EBITDA Margin & Revenue for ALS excludes non-laboratory businesses but does include all corporate expenses. Data for Financial Year ending March 2013 based on current guidance.

10

Operating EBITDA Margin by Division

==> picture [45 x 44] intentionally omitted <==

==> picture [565 x 311] intentionally omitted <==

----- Start of picture text -----

45%
40%
35%
30%
25%
20%
15%
10%
5%
0%
FY2009 FY2010 FY2011 FY2012 H1 FY2013
Minerals Life Sciences Energy Industrial
EBITDA Margin
----- End of picture text -----

EBITDA margins exclude ALS Limited Corporate Costs

==> picture [720 x 37] intentionally omitted <==

CAPEX (excluding properties) and Depreciation

50 CAPEX increased to accelerate expansion of 45 non-geochemistry businesses and upgrade more recent acquisitions to improve margins 40 35 30 25 20 15 10 5 - Capex (excl properties) Depreciation

==> picture [41 x 41] intentionally omitted <==

==> picture [45 x 44] intentionally omitted <==

12

12

Conservative Funding

==> picture [45 x 44] intentionally omitted <==

Mar-09 Mar-10 Mar-10 Mar-11 Mar-12 Jan-13
Statistics
Gearing Ratio Comfort 45% 33.7% 18.9% 11.9% 28.5% 28.8%
Leverage (net debt / EBITDA) Max 3.00 1.04 0.94 0.47 0.99 1.04
EBITDA interest cover Min 3.75 14.0 14.1 23.2 23.9 21.1
Balance Sheet Measures
Total Equity 413 630 826 930 1034
Net debt 210 147 111 370 417
0
50
100
150
200
250
AUD $million
33.8%
7.6%
4.6%
14.5%
18.3%
21.3%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Long term Debt - USPP Notes
Bank Debt - Undrawn Capacity
Bank Debt Drawn
(Weighted average maturity: 6.15 years)

Facility Maturity

13

What makes us different

==> picture [45 x 44] intentionally omitted <==

  • Assets

  • State of the art laboratories

  • High end technical services

  • Unique service offerings

  • Operating Model

  • Hub and spoke

  • Centres of Excellence

  • Systems and standards

  • “Decentralised” laboratory Vs many laboratories

  • People

  • Training

  • Passion

  • Culture

  • Loyalty

  • Communication

  • Strategy

  • Long-term horizon

  • Focus

==> picture [135 x 134] intentionally omitted <==

==> picture [165 x 125] intentionally omitted <==

  • Execution

==> picture [162 x 85] intentionally omitted <==

14

What makes us different

==> picture [45 x 44] intentionally omitted <==

  • Management Information Systems (MIS)

  • LIMS

    • GEMS – Geochemical

    • Coal8 – Coal

    • EnviroLIMS – Environmental

    • SAM – Tribology

    • ELMS – Food

    • OSPrey – Asset Care

  • Webview – Management Interface

  • WebTrieve[TM ]

  • Other Portals

==> picture [360 x 190] intentionally omitted <==

  • iLEAD – training

  • EPC – succession planning

  • Compliance

  • Financial – TM1

  • CAPEX

  • Safety Tracking

  • Human Resources

  • Business stream Sharepoint sites

  • • Support group Sharepoint sites

==> picture [253 x 141] intentionally omitted <==

15

World Exploration Trends (excl. iron ore & coal)

==> picture [45 x 44] intentionally omitted <==

  • Data from Metals Economic Group Report December 2012 -

Gold– 23 year history Copper – 24 year history

Zinc– 24 year history

16

==> picture [45 x 44] intentionally omitted <==

ALS Geochemistry Revenue CY2012

==> picture [667 x 347] intentionally omitted <==

----- Start of picture text -----

100%
90%
80% 33%
70%
60%
24%
50%
40% greenfield
30%
brownfield
43%
20%
10%
0%
North South Africa Australia Europe Asia Total
America America
Majors Intermediates Juniors
----- End of picture text -----

50% of all geochemistry work comes from existing mining operations

==> picture [720 x 37] intentionally omitted <==